Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership
MIAMI, June 17, 2025 /PRNewswire/ -- Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the establishment of its new U.S. headquarters in Miami, Florida, positioning the company at the heart of a thriving market for Dermatological Skincare and Injectable Aesthetics. Located in the vibrant Brickell neighborhood, the company expects to have approximately 150 employees, including U.S. leadership roles, based there by 2028.
Miami's emergence as a premium market and destination for consumer skincare, consumer health, and aesthetic treatments aligns closely with Galderma's ambitions for its U.S. business, which is the company's largest region globally and a key driver of future growth.
"Miami's creativity, energy and forward-thinking spirit are consistent with Galderma's ambitions. The city's emergence as a premium destination and a trend-setter in areas closely aligned to our activities, as well as its fast-growing healthcare professional community, makes Miami a natural choice for our U.S. headquarters. Being in Miami will enrich our business with top talent that will prove invaluable to our future success."
FLEMMING ØRNSKOV, M.D., MPH CHIEF EXECUTIVE OFFICERGALDERMA
The Miami metro area boasts one of the highest concentrations of medical spas and dermatological aesthetic clinics in the United States, with aesthetic procedures growing at an estimated 30% year-over-year. It also hosts the nation's second-largest medical district, the Miami Health District, with numerous hospitals and research facilities. With over 186,000 healthcare-related jobs and significant growth in startups, Florida is a hub for innovation in health and advanced medical technologies. Miami plays an important role in this ecosystem, with renowned research institutions and medical centers that house dedicated clinical teams focused on dermatology.
"We are delighted to welcome Galderma to the Miami-Dade County area, which has witnessed considerable growth recently as companies increasingly find it to be an attractive location for investment. Miami-Dade has established itself as a key player in the life sciences and healthcare industry and having the pure-play dermatology industry leader anchor its U.S. business here will only bolster the region's reputation for innovation in this sector."
RODRICK MILLERPRESIDENT AND CHIEF EXECUTIVE OFFICERMIAMI-DADE BEACON COUNCIL
In addition to its new headquarters in Miami, Galderma will maintain a strong presence across several U.S. locations. Boston, MA, will remain the hub for the company's U.S. Therapeutic Dermatology business and U.S. Research and Development organization. Carlsbad, CA, will continue as a hub for Alastin®, the company's premium, physician-dispensed skincare brand. The Dallas, TX, office will continue as one of Galderma's key U.S. sites while the company's North America distribution center will remain in Fort Worth, TX.
APPOINTING A NEW LEADER FOR GALDERMA U.S.Galderma has also announced today the appointment of Heather Wallace as President of Galderma U.S. Heather will be based in Miami. A proven senior business leader with deep expertise in dermatology and consumer health, she brings a strong track record of delivering commercial success and operational excellence.
Heather previously led high-performing teams as Chief Executive Officer of Curology, the leader in personalized prescription skincare, and as President of the Americas region for Revlon, where she oversaw strategic and cultural transformation efforts to maximize profitability in the company's largest region. Her appointment signals Galderma's commitment to strengthening its U.S. leadership with forward-thinking talent capable of driving sustained growth in a dynamic and highly competitive landscape.
GALDERMA'S LEADING PORTFOLIO OF PREMIUM BRANDSGalderma's synergistic portfolio of flagship brands holds leading market positions in Dermatological Skincare, Injectable Aesthetics, and Therapeutic Dermatology.
In Dermatological Skincare, Galderma is best known for Cetaphil®, a leading dermatologist recommended brand for sensitive skin with more than 70-year heritage in the United States. Galderma's premium portfolio also includes the physician-dispensed skincare brand Alastin®, a leader in medical-grade peptide-based regenerative skincare.
In Injectable Aesthetics, Galderma has a long history of aesthetics innovation and deep expertise in neuromodulators, as well as hyaluronic acid (HA) fillers and biostimulators.
In Therapeutic Dermatology, Galderma brands hold leading positions in acne and rosacea and the company recently launched the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signaling of IL-31 in prurigo nodularis and atopic dermatitis.
ABOUT GALDERMAGalderma (SIX: GALD) is the pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body's largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals. Because we understand that the skin we are in shapes our lives, we are advancing dermatology for every skin story. For more information: www.galderma.com.
For further information:
Christian Marcoux, M.Sc.
Chief Communications Officer
christian.marcoux@galderma.com
+41 76 315 26 50
Jeffrey Smith
Head of U.S. Communications
jeffrey.smith@galderma.com
+1 (682) 401-8428
Richard Harbinson
Corporate Communications Director
richard.harbinson@galderma.com
+41 76 210 60 62View original content to download multimedia:https://www.prnewswire.com/news-releases/galderma-establishes-new-us-headquarters-in-miami-and-strengthens-regional-leadership-302483954.html
SOURCE Galderma
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
a minute ago
- CBS News
Technology meets hospitality at high tech coffee kiosk in downtown Denver
Denver's 16th Street is nearing the finish line on its $175.4 million revitalization project, and new businesses are quickly filling in. Among them is Javai Coffee, a tech-forward coffee shop that's offering more than just a fresh cup of Joe. Located at 16th Street and Wazee Street, Javai operates a 24/7 automated robotic coffee kiosk, serving up espresso drinks in less than 60 seconds. Co-owner Grant Ross says the $22,000 machine is designed to be both efficient and inclusive, giving downtown workers, tourists, and late-night crowds access to affordable coffee at any hour. But Ross emphasizes that the model isn't about replacing jobs. Instead, Javai hires local service technicians to maintain the machine, stocking it with fresh milk and beans sourced from Colorado vendors. "We're not taking barista jobs, we're creating opportunities," Ross explained. "We want everything about this to be Colorado, from the ingredients to the people keeping it running." As 16th Street re-establishes itself as a hub for business and entrepreneurship, Ross believes Javai can play a role in that growth. "This is where we're starting. We want to own 16th Street so people can have affordable, quality coffee," he said. For a corridor that has long been considered the backbone of downtown Denver, Javai Coffee represents both innovation and investment, a blend fueling the future of the city's economy one cup at a time.
Forbes
a minute ago
- Forbes
Are Browsers Key To An Agentic AI Future? Opera, Perplexity Think So
AI-powered conversational search engine Perplexity is in the news for offering to buy Google's Chrome browser for $34.5 billion. But in December of 2024, Perplexity considered buying The Browser Co. And just months ago, Perplexity reportedly offered to buy Brave, the privacy-focused browser, for about $1 billion. Why does Perplexity want a web browser so badly? Possibly because a browser just might be key to our agentic AI future. I recently interviewed Opera senior product leader Henrik Lexow on my TechFirst podcast. Opera, the 30-year-old browser company that pioneered tabbed browsing, pop-up blocking, and ad blockers, has about 300 million active users globally. This year, Opera was the first to bring AI agents right into our browsers in a project called Opera Neon. 'The agentic browser … is that sort of the new operating system?' Lexow asked during the podcast. 'It's a big question.' Regardless of where the browser goes, Opera's pretty sure about the future of the internet itself. That's a huge shift, by the way. An agentic internet would be a massive and fundamental change from a user-driven internet to an agent-driven version. In a user-driven internet, you search, you see results, you make selections, you click links, you fill out forms, you book flights, and you buy products. In a sense, you are the agent. In an agentic internet, you tell something – maybe your agentic browser – to do those things for you. Except you don't say search, look, select, and buy; you say buy me more of the underwear I got six months ago. The agent then consults its memory, forms a plan, takes multiple steps, and handles it all: from which underwear you bought, and where you bought them, to finding the same ones online (and maybe checking around for better prices), to adding them to cart, to checking out … and reporting back to you with the results. The agent – in this case potentially an agentic browser – is therefore essentially a personal assistant, a force multiplier. But will an agentic browser be the main way we engage with agents? Perplexity seems to think it's pretty important, given the company's persistent and repeated but so far unfruitful attempt to buy a browser. Opera certainly thinks so, if only because Opera has a browser, and a very innovative one at that. Opera launched AI in a browser back in 2023 in a project called ARIA. ARIA enabled contextual interactions within web pages in a GPT-based chat interface. Over time, that's evolved to a tripartite strategy under the Opera Neon brand: The reality is that for many of us, most of our work happens in a browser. I'm writing this story in a browser. I recorded the interview in a browser. I've researched Opera and Perplexity in a browser. I made episode art for the podcast in a browser (thanks, Canva). Opera's thesis is that having agents embedded where you work makes them vastly more useful: they have access to your history, to your work, to your sites and apps. Important note: the Neon agentic browser's AI lives locally on your hardware, making it your agent, not Opera's, and not your employer's. This should boost your privacy, which is critical if you're going to give an agent access to very personal information including, likely, your credit card. Of course, this is just one vision of the future. Apple with Siri, as justly maligned as it is, would have another vision. Google, with Gemini and its own vast fleet of Android-enabled phones, would have another. Microsoft's Copilot is another. And OpenAI, which has ChatGPT apps for mobile devices as well as full computers, might have yet another vision of how we'll integrate AI into our lives and work. So whether the browser will be the locus of our agentic AI future or not is yet to be determined. Remember the old proverb: every problem looks like a nail to the person who only has a hammer. But it seems like a fairly good bet to me.
Yahoo
29 minutes ago
- Yahoo
Mega $33M office-shipping center near N.J. Turnpike to open next year
The Joyce Kilmer Logistics Center, a new $33 million industrial project in Middlesex County, is expected to be completed in 2026. Faropoint and Deugen Development closed on the construction loan for the 195,421-square-foot complex this summer, according to a news statement issued by Cushman & Wakefield, which arranged the loan. The center, located at 701 Joyce Kilmer Ave. in New Brunswick, will feature 36-foot clear ceiling heights, 32 loading docks and electric vehicle parking spaces, and modern office space, according to the statement. It is designed to accommodate mid-sized users, with the flexibility to divide into smaller units ranging from 40,000 to 50,000 square feet. The project is strategically positioned near major transportation routes including the New Jersey Turnpike (I-95) and Route 1, providing easy access to key consumer markets in New York City and Philadelphia. 'The Exit 9 industrial corridor has become a gateway for commerce in the northeast and has benefitted from a rapid surge in demand for modern industrial facilities, driven by e-commerce growth and supply chain optimization,' said Brad Domenico of Cushman & Wakefield. The development also addresses a specific market need, according to Orry Michael, vice president of Northeast Acquisitions at Faropoint, who said there is a 'limited supply of new Class A product with suites under 100,000 square feet in this Exit 9 micro-location.' Generative AI was used to produce an initial draft of this story, which was reviewed and edited by NJ Advance Media staff.
